5 Years Development

Income Statement (MEUR)

  IFRS 2021
Continuing operations
IFRS 2020
Continuing operations
IFRS 2019
Continuing operations
IFRS 2018
Continuing
operations
IFRS 2017
Continuing
operations
Net sales, (MEUR) *) 86.9 78.4 75.2 62.8 51.6
     Net sales change, % 10.8 4.2 19.7 21.7 -19.6
Operating profit/loss, (MEUR) *) 3.2 2.1 6.3 2.8 -6.2
     % of net sales 3.7 2.7 8.4 4.5 -12.0
Profit / loss for Continuing Operations before taxes, (MEUR) 2.5 1.6 5.9 2.7 -5.8
     % of net sales 2.9 2.1 7.9 4.3 -11.3
Profit of the year from Continuing Operations, (MEUR) 3.3 2.2 7.6 4.0 -4.8
     % of net sales 3.8 2.8 10.2 6.4 -9.2
Profit after tax for the year from Discontinued Operations, (MEUR) 0 0 0 0 1.7
     % of net sales 0 0 0 0 3.2
Profit for the year attributable to equity holders of the parent, (MEUR) 3.3 2,2 7.6 4.0 -3.1
     % of net sales 3.8 2,8 10.2 6.4 -6.0

Balance sheet (MEUR)

  IFRS 2021
Continuing operations
IFRS 2020
Continuing operations
IFRS 2019
Continuing operations
IFRS 2018
Continuing operations
IFRS 2017
Continuing
operations
Non-current assets 85.9 86.4 80.5 65.9 46.7
Inventories 18.8 20.9 18.2 14.6 10.6
Current assets 61.4  50.7  55.6 51.9 81.1
Assets classified as held for sale          
Sharelolders' equity 116.8 114.2 112.3 110.0 116.7
Non-current liabilities 21.5 21.9 22.1 1.9 1.5
Current liabilities 27.8 21.8 19.9 20.5 20.2
Liabilities classified as held for sale          
Balance sheet total 166.1 158.0 154.2 132.4 138.4

Profitability and Other Key Figures

  IFRS 2021
Continuing operations
IFRS 2020
Continuing operations
IFRS 2019
Continuing operations
IFRS 2018
Continuing operations
IFRS 2017
Continuing
operations
Return on equity, % (ROE) 2.9  1.9  6.9 3.6 -3.9
Return on investment % (ROI) 2.3  1.6  5.0 3.7 -4.5
Interest-bearing net liabilities, (MEUR) 0.2 -2.1 -12.6 -29.4 -61.7
Net gearing, % 0.2 -1.9 -11.2 -26.7 -52.9
Equity ratio, % 72.4 73.1 73.4 84.7 85.6
Gross investments, (MEUR) *) 9.6 17.4 21.3 21.2 20.1
     Gross investments, % of net sales 11.0 22.2 28.3 33.8 38.8
R&D costs, (MEUR) *) 19.8 22.8 25.1 21.6 15.0
     R&D costs, % of net sales 22.8 29.1 33.4 34.4 29.1
Average personnel during the period, parent and subsidiaries *) 664 673 665 660 614

Stock-Related Financial Ratios

  IFRS 2021 IFRS 2020 IFRS 2019 IFRS 2018 IFRS 2017

Earnings per share from continuing operations, EUR
         
     Basic earnings per share 0.093 0.061 0.214 0.113 -0.133
     Diluted earnings per share 0.093 0.061 0.214 0.113 -0.133

Earnings per share from discontinued operations, EUR
         
     Basic earnings per share         0.046
     Diluted earnings per share         0.046

Earnings per share from continuing and discontinued operations, EUR
         
     Basic earnings per share 0.093 0.061 0.214 0.113 -0.087
     Diluted earnings per share 0.093 0.061 0.214 0.113 -0.087
Equity per share, EUR 3.27 3.2 3.15 3.08 3.27
Dividend per share, EUR *) 0.04 0.0 0.1 0.15 0.3
Dividend per earnings, % 44.6 0.0 46.7 132.7 -344.6
P/E ratio 43.0  94.9 30.4 53.0 -64.9
Effective dividend yield, % 0.8  0.5 0.0 2.0 5.3

Market values of shares (EUR)
         
     Highest 7.89 7.67 8.03 8.1 7.88
     Lowest 4.93 3.40 5.91 4.71 5.55
     Average 6.18 5.74 6.70 5.98 6.55
     At the end of period 5.30 5.79 6.50 7.61 5.65
Market value of the stock, (MEUR) 189.2 206.7 232.0 271.6 201.7

Trading value of shares
         
     MEUR 83.2 117.9 51.5 75.4 83.1
     1000 pcs 13 464 20 557 7 689 12 608 12 684
     Related to average number of shares % 37.7 57.6 21.5 35.3 35.5
Adjusted number of the shares at the end of the period (1000 pcs) 35 700 35 693 35 693 35 693 35 693
Adjusted number of the shares average during the period (1000 pcs) 35 700 35 693 35 693 35 693 35 693
Adjusted number of the shares average for the period diluted with stock options (1000 pcs) 35 700 35 693 35 693 35 693 35 693


*) Proposal of the BoD for 2022